Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer
Active-not-recruiting breast cancer trial investigating metastatic markers of recurrent tumor phenotype conducted under the 2-PREVENT Transl…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: [18F] F-GLN by PET/CT in Breast Cancer [Phase 1]
A Phase 1 clinical trial evaluating the PET imaging tracer [18F] F-GLN for breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating OCT-598 in patients with advanced solid tumors; the study is currently recruiting and includes multiple tu…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases [Phase 2]
Phase 2 trial evaluating GDC-0084 in combination with trastuzumab for HER2-positive breast cancer with brain metastases has been terminated.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer
A clinical trial investigating the efficacy and safety of trastuzumab-rezetecan in HER2-expressing breast cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy [Phase 4]
A Phase 4 clinical trial update evaluating six months of HER2-targeted therapy in patients with HER2-positive early-stage breast cancer who …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy [Phase 3]
A Phase 3 clinical trial comparing BL-M07D1 to T-DM1 as adjuvant therapy for HER2-positive breast cancer with residual invasive disease afte…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer [Phase 3]
A Phase III clinical trial evaluating brain MRI surveillance in stage IV breast cancer is planned; recruitment is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy [Phase 3]
A Phase 3 clinical trial is evaluating metformin for treating insulin resistance in women with Stage I-III breast cancer who have completed …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) [Phase 2]
Phase 2 randomized CAPELA trial comparing capecitabine plus elacestrant versus capecitabine alone in estrogen receptor–positive breast cance…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects With HR-Positive/HER2-Negative Solid Tumor [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics and efficacy of HRS-6209 in HR-positive/HER2-negative breast cancer. T…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery [Phase 3]
Phase 3 clinical trial update on using fulvestrant and/or anastrozole in postmenopausal patients with Stage II–III breast cancer undergoing …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC [Phase 2]
A Phase 2 clinical trial is evaluating the combination of sacituzumab govitecan and bevacizumab in metastatic triple-negative breast cancer,…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy [NA]
This update notes that a clinical trial is recruiting to test whether high-intensity interval training improves cognitive function in breast…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer [NA]
This clinical trial update covers a study evaluating a radiation therapy boost given before surgery for non-metastatic breast cancer. The tr…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Trans-RosaLEE Study: a Biomarker-directed, Translational Study [NA]
Clinical trial update for Trans-RosaLEE, a biomarker-directed translational study in advanced or metastatic breast cancer; the trial is curr…
-
CLINICAL_TRIALS other · 2026-01-22Clinical Trial Update: An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer. [Phase 4]
Open-label, single-arm Phase 4 trial assessing prophylaxis for datopotamab deruxtecan–related stomatitis in patients with metastatic or inop…
-
EMA approval · 2026-01-21EMA Authorised: Abraxane (paclitaxel) — Bristol-Myers Squibb Pharma EEIG
EMA authorised Abraxane (paclitaxel) by Bristol-Myers Squibb Pharma EEIG for breast cancer, pancreatic cancer, and non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer [Phase 2]
This clinical trial update reports Phase 2 results on the response rate of neoadjuvant docetaxel (Taxotere) in combination with trastuzumab …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) [Phase 3]
Phase 3 CHESS trial evaluating CDK4/6 inhibitors added to standard adjuvant endocrine therapy for high-risk HR+/HER2+ early breast cancer; c…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: The Effect of Nurse-Led Coaching Program on Self-Care Agency and Quality of Life in Reconstructed Breast Cancer Patients [NA]
This clinical trial update describes the evaluation of a nurse-led coaching program for breast reconstruction patients, focusing on self-car…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer [Phase 2]
A Phase 2 trial is evaluating ctDNA-guided de-escalation of adjuvant chemotherapy using dalpiciclib in HR-positive, HER2-negative breast can…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors [Phase 1]
A Phase 1 trial evaluating BL-M17D1 in locally advanced or metastatic breast cancer (HER2 positive and negative) and other solid tumors is c…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients [NA]
This clinical trial update describes a self-monitoring platform to track medication safety concerns in cancer patients, sponsored by the Uni…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer [NA]
A clinical trial evaluating a one-week adjuvant regional nodal radiation therapy for breast cancer. The study is currently ACTIVE_NOT_RECRUI…